Autres

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Autres

01. Juin 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3755


	Articles 1 - 20 / 75081

	Prevalence of metabolic associated fatty liver disease (MAFLD) and its associated factors among type 2 diabetes mellitus (T2DM) in primary care settings in Kuantan, Pahang. Med J Malaysia Jamani NA, Zainun N, Abd Rahman MA, Abd Aziz KH, Che Yusuf MD. PMID: 42216749 [PubMed - indexed for MEDLINE]
	Association between lactate-to-albumin ratio and all-cause mortality in critically ill hepatic failure patients with sepsis: A retrospective cohort study. Medicine (Baltimore) Li J, Pang S, Ye X, Huang H, Wu J, Hu D, Chen M. PMID: 42216409 [PubMed - indexed for MEDLINE]
	The neutrophil-to-lymphocyte ratio predicts all-cause and cardiovascular mortality in patients with nonalcoholic fatty liver disease: Evidence from the National Health and Nutrition Examination Survey 1999 to 2018. Medicine (Baltimore) Du Z, Jiang J, Lv X, Hou Y, Li D. PMID: 42216404 [PubMed - indexed for MEDLINE]
	Associations of TyG-related indices with NAFLD-related outcomes: A systematic review and meta-analysis. Medicine (Baltimore) Li J, Liu W. PMID: 42216403 [PubMed - indexed for MEDLINE]
	Impact of housing instability on hospital outcomes in alcohol-associated liver disease: A single-center retrospective cohort study. Medicine (Baltimore) Lee KJ, Fan GH, Huang A, Karagozian R, Almeqdadi M. PMID: 42216325 [PubMed - indexed for MEDLINE]
	Network toxicology-driven insights on nitrogen-based flame retardant-induced hepatotoxicity: Computational prediction and experimental validation. Medicine (Baltimore) Qu Y, Li G, Wang H, Peng Y. PMID: 42216319 [PubMed - indexed for MEDLINE]
	Fecal Proteomics Suggest Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Steatohepatitis. Proteomics Clin Appl Negroni A, Pieroni L, Fiaschini N, Palone F, Mancuso M, Vitali R. PMID: 42216306 [PubMed - indexed for MEDLINE]
	Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options. Mol Biomed Ren R, Liang X, Wei X. PMID: 42215843 [PubMed - indexed for MEDLINE]
	[Recent Advances in the Diagnosis and Management of Wilson's Disease]. Dtsch Med Wochenschr Merle U. PMID: 42214358 [PubMed - indexed for MEDLINE]
	Implementation of Mobile-Based Programs for Alcohol Cessation in the Treatment of Alcohol-associated Liver Disease: Protocol for a Type 1 Hybrid Implementation-Effectiveness Trial. JMIR Res Protoc He C, Edwards J, Park LS, Herzog M, Li X, Pulvermacher A, Mundt MP, Brown R, Mellinger J, Quanbeck A. PMID: 42214070 [PubMed - indexed for MEDLINE]
	TIME-RESTRICTED EATING IN MASLD: THE IMPERATIVE TO PRESERVE MUSCLE MASS AND PREVENT WEIGHT CYCLING FOR SUSTAINABLE CLINICAL BENEFIT. Arq Gastroenterol Ketenci YB, Demiröz H, Akca M. PMID: 42207075 [PubMed - indexed for MEDLINE]
	Metabolomic signatures mediate the association between physical frailty and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study. Front Endocrinol (Lausanne) Li D, Bo Y, Chen Y, Guo Z, Li L, Zhang W, Xue M, Zhu Y, Ren L, Li T, Gao Z. PMID: 42205264 [PubMed - indexed for MEDLINE]
	Identification of candidate biomarkers for NAFLD through bioinformatics analysis and machine learning based on circulating insulin degradation-associated genes. Front Endocrinol (Lausanne) Guo M, Lou W, Song X, Gao D, Wang G, Ma H, Wang W, Wang Y. PMID: 42205256 [PubMed - indexed for MEDLINE]
	Histopathological Assessment Using SAF Scoring: Investigating Risk Factor Correlations with Disease Severity in MASLD Patients. Biomed Environ Sci Li XX, Zhang YQ, Wang SJ, Gao ZX, Xie Y, Li MH, Gao YJ. PMID: 42205022 [PubMed - indexed for MEDLINE]
	Combined Liver-Small Bowel Transplant in Children. Gastroenterol Clin North Am Alaniz MJ, Withington C, Tzvetanov IG, Benedetti E. PMID: 42203394 [PubMed - indexed for MEDLINE]
	Building capacity for patient advocacy in liver health: a cross-country qualitative study. BMJ Open Barello S, Monaci M, Credi B, Korenjak M, Bigi S. PMID: 42203281 [PubMed - indexed for MEDLINE]
	Evaluation of Sarcopenic Obesity in Patients with MASLD. Med Sci (Basel) Mourelatou NG, Bali T, Adamantou M, Chrysavgis L, Chologkitas C, Sarri M, Pavlopoulou D, Schinas G, Androutsakos T, Sypsa G, Karagiannakis DS, Papatheodoridis G, Tentolouris N, Mavrogiannaki AN, Cholongitas E. PMID: 42201049 [PubMed - indexed for MEDLINE]
	Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control. Drug Des Devel Ther Liu J, Li F, Zeng Q, Hu W, Yang L, Luo S, Lv F, Li D, Deng Y. PMID: 42199808 [PubMed - indexed for MEDLINE]
	Dapagliflozin and linagliptin combination therapy improves time in range and reverses hepatic steatosis in patients with type 2 diabetes and hypertension. Front Endocrinol (Lausanne) Li W, Li R, Li S, Li Z, Ma J, Wu F, Chen C. PMID: 42199793 [PubMed - indexed for MEDLINE]
	Research Progress on Mesenchymal Stem Cells-Derived Small Size Vesicles for the Treatment of Liver Diseases. Int J Nanomedicine Meng C, Liu M, Qi Q, Cao L, Lei Q, Liu X, Wang M. PMID: 42199661 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 75081

Page 1 de 3755



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité